Yanuki
Health / Weight Loss
The market for weight-loss drugs is heating up as Novo Nordisk, the maker of Wegovy, takes legal action against telehealth companies like Hims & Hers for offering compounded versions of its popular medication. This comes as analysts see a p...
Pharmaceuticals / Weight Loss
Novo Nordisk is set to initiate legal proceedings against Hims & Hers following the announcement of a $49 copy of Novo's Wegovy weight loss pill. This move comes as Hims & Hers aims to offer a more affordable alternative to the branded medi...
Health / Pharmaceuticals
Online telehealth company Hims & Hers is set to launch a copy of the Wegovy pill for $49, significantly undercutting Novo Nordisk’s $149 branded version. This announcement has sent shockwaves through the pharmaceutical market, impacting the...
Health / Weight Loss
Novo Nordisk is providing discounts on Ozempic and Wegovy for individuals paying out-of-pocket, aiming to improve access to these medications.
Health / Prescription Drugs
Novo Nordisk has announced a price reduction for its popular weight loss drug Wegovy and diabetes medication Ozempic, aiming to make them more accessible to patients paying out-of-pocket. This move follows agreements with the Trump administ...
Health / Weight Loss
Costco is now offering Ozempic and Wegovy at a discounted price for members with a prescription, partnering with Novo Nordisk to make these weight loss drugs more accessible. This initiative aims to provide a more affordable option for indi...
News / Pharmaceuticals
Recent studies and lawsuits are raising concerns about a potential link between popular diabetes and weight loss drugs—Ozempic, Wegovy, and Mounjaro—and an increased risk of vision loss. This article breaks down the key findings and what yo...
Health & Science / Pharmaceuticals
Novo Nordisk's Wegovy has received U.S. FDA approval for treating metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis. This is a significant development as Wegovy becomes the first GLP-...
Health / Weight Loss
Novo Nordisk has announced a collaboration with WeightWatchers to broaden patient access to Wegovy, an FDA-approved medication for weight loss. Starting July 1, WeightWatchers will partner with CenterWell Pharmacy to manage prescription ful...
Health / Weight Loss
Recent findings from a head-to-head trial have shed light on the effectiveness of two popular weight-loss drugs: Mounjaro (Tirzepatide) and Wegovy (Semaglutide). The study, published in the New England Journal of Medicine, directly compares...
Healthcare / Pharmaceuticals
Novo Nordisk A/S (NVO), the Denmark-based global healthcare giant, is currently a focal point in the pharmaceutical sector. Fueled by the success of its popular diabetes and obesity treatments like Ozempic and Wegovy, the company's strong f...
Health / Weight Loss
Blockbuster weight loss drugs like Ozempic and Mounjaro are surging in popularity, with estimates suggesting one in eight Americans have used them. While effective for shedding pounds, they come with a growing list of side effects. The late...
